E
Elizabeth M. Anderson
Researcher at University of Pennsylvania
Publications - 38
Citations - 5508
Elizabeth M. Anderson is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & T cell. The author has an hindex of 22, co-authored 37 publications receiving 3702 citations. Previous affiliations of Elizabeth M. Anderson include The Catholic University of America & Western Washington University.
Papers
More filters
Journal ArticleDOI
Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection
Mary F. Kearney,Jonathan Spindler,Ann Wiegand,Wei Shao,Elizabeth M. Anderson,Frank Maldarelli,Francis W. Ruscetti,John W. Mellors,Steve H. Hughes,Stuart F. J. Le Grice,John M. Coffin +10 more
TL;DR: Results indicate that MLV DNA detected in the plasma samples from CFS patients evaluated in this study was from contaminating mouse genomic DNA and that XMRV detected in Plasma samples from healthy controls and in cultures of patient samples was due to cross-contamination with XMRv (virus or nucleic acid).
Journal ArticleDOI
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
Elizabeth M. Anderson,Caroline Diorio,Eileen C. Goodwin,Kevin O McNerney,Madison E. Weirick,Sigrid Gouma,Marcus J. Bolton,Claudia P. Arevalo,Julie Chase,Philip Hicks,Tomaz B. Manzoni,Amy E. Baxter,Kurt P Andrea,Chakkapong Burudpakdee,Jessica H. Lee,Laura A. Vella,Laura A. Vella,Sarah E. Henrickson,Rebecca M. Harris,E. John Wherry,Paul Bates,Hamid Bassiri,Edward M. Behrens,David T. Teachey,Scott E. Hensley +24 more
TL;DR: It is shown that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
Journal ArticleDOI
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Caroline Diorio,Elizabeth M. Anderson,Kevin O McNerney,Eileen C. Goodwin,Julie C. Chase,Marcus J. Bolton,Claudia P. Arevalo,Madison E. Weirick,Sigrid Gouma,Laura A. Vella,Sarah E. Henrickson,Kathleen Chiotos,Julie C. Fitzgerald,Todd J. Kilbaugh,Audrey R. Odom John,Allison M Blatz,Michele P. Lambert,Kathleen E. Sullivan,Margaret R. Tartaglione,Danielle Zambrano,Meghan Martin,Jessica H. Lee,Pampee P. Young,David F. Friedman,David F. Friedman,Deborah A. Sesok-Pizzini,Scott E. Hensley,Edward M. Behrens,Hamid Bassiri,David T. Teachey +29 more
TL;DR: It was found CP was safe and possibly efficacious, and not associated with antibody‐dependent enhancement (ADE) and did not suppress endogenous antibody response.
Posted ContentDOI
SARS-CoV-2 Seroprevalence Among Parturient Women
Dustin D. Flannery,Dustin D. Flannery,Sigrid Gouma,Miren B. Dhudasia,Sagori Mukhopadhyay,Sagori Mukhopadhyay,Madeline R. Pfeifer,Emily C. Woodford,Jeffrey S. Gerber,Jeffrey S. Gerber,Claudia P. Arevalo,Marcus J. Bolton,Madison E. Weirick,Eileen C. Goodwin,Elizabeth M. Anderson,Allison R. Greenplate,Justin Kim,Nicholas Han,Ajinkya Pattekar,Jeanette Dougherty,Olivia Kuthuru,Divij Mathew,Amy E. Baxter,Laura A. Vella,Laura A. Vella,JoEllen Weaver,Anurag Verma,Rita Leite,Jeffrey S. Morris,Daniel J. Rader,Michal A. Elovitz,E. John Wherry,Karen M. Puopolo,Karen M. Puopolo,Scott E. Hensley +34 more
TL;DR: Serological tests are critically important to determine exposure and immunity to SARS-CoV-2 within both individuals and populations and race/ethnicity differences in seroprevalence rates are found.
Journal ArticleDOI
Challenges of Making Effective Influenza Vaccines
TL;DR: It is argued that seasonal influenza vaccines can be dramatically improved by modernizing antigen production processes and developing models that are better at predicting viral evolution.